SCHEMBL18554254

SCHEMBL18554254

COc1ccc(Cn2cnc3c([AsH]c4ccnc(NC(C)=O)c4)nc(-c4cccc(C)n4)nc32)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 3/20 0.40
TGFBR2 P37173 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.38
POLB P06746 1/20 0.38
ADORA2A P29274 3/20 0.37
CYP3A4 P08684 1/20 0.37
NR3C1 P04150 3/20 0.37
HDAC1 Q13547 2/20 0.37
HDAC3 O15379 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
ALDH1A1 P00352 1/20 0.36
MAPK10 P53779 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
YTHDC1 Q96MU7 3/20 0.36
CTSL P07711 2/20 0.36
PDGFRA P16234 1/20 0.35
CCNE1 P24864 1/20 0.35
CDK2 P24941 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18554252 0.92 ADORA2A (0.42) TGFBR1TGFBR2SMN1; SMN2POLBADORA2A
SCHEMBL18554321 0.91 TGFBR1 (0.42) TGFBR1TGFBR2SMN1; SMN2POLBADORA2A
SCHEMBL18554274 0.86 TGFBR1 (0.53) TGFBR1TGFBR2SMN1; SMN2POLBHDAC1
SCHEMBL29363064 0.77 POLB (0.39) SMN1; SMN2POLBADORA2ANR3C1HDAC1
SCHEMBL22978895 0.77 POLB (0.39) SMN1; SMN2POLBADORA2ANR3C1HDAC1
SCHEMBL18554193 0.77 TGFBR1 (0.55) TGFBR1TGFBR2HDAC1HDAC3HDAC2
SCHEMBL18554233 0.76 TGFBR1 (0.52) TGFBR1TGFBR2ADORA2ACYP3A4HDAC1
SCHEMBL18583774 0.76 TGFBR1 (0.56) TGFBR1TGFBR2HDAC1HDAC3HDAC2
SCHEMBL22978902 0.75 ADORA2A (0.46) ADORA2ANR3C1HDAC1HDAC2HDAC6
SCHEMBL29365625 0.75 ADORA2A (0.46) ADORA2ANR3C1HDAC1HDAC2HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3341372-A1 TGF BETA RECEPTOR ANTAGONISTS Bristol-Myers Squibb Company (US) 2018-07-04 EP disclosed
WO-2017035118-A1 TGF BETA RECEPTOR ANTAGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2017-03-02 WO disclosed